Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Casi Pharmaceuticals Inc (NQ: CASI )

2.350 +0.110 (+4.89%)
Streaming Delayed Price Updated: 10:10 AM EDT, Apr 18, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 4,631
Open 2.280
Bid (Size) 2.270 (1)
Ask (Size) 2.370 (4)
Prev. Close 2.240
Today's Range 2.280 - 2.360
52wk Range 1.850 - 8.480
Shares Outstanding 13,457,625
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
CASI Stock Earnings: CASI Pharmaceuticals Misses EPS, Misses Revenue for Q4 2023
CASI stock results show that CASI Pharmaceuticals missed analyst estimates for earnings per share and missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Recap: CASI Pharmaceuticals Q4 Earnings
Via Benzinga

Performance

YTD
-67.46%
-67.46%
1 Month
-22.46%
-22.46%
3 Month
-52.53%
-52.53%
6 Month
-17.21%
-17.21%
1 Year
-26.80%
-26.80%

More News

Read More
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
CASI Pharmaceuticals Blood Cancer Drug Shows Encouraging Clinical Efficacy In Chinese Patients
Via Benzinga
CASI Pharmaceuticals: Q1 Earnings Insights
Via Benzinga
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
Via Benzinga
CASI Pharmaceuticals's Return On Capital Employed Insights
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Week In Review: LianBio To Close Operations; Will Pay $528 Million To Shareholders
Via Talk Markets
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
HC Wainwright & Co. Maintains Buy Rating for CASI Pharmaceuticals: Here's What You Need To Know
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
Why VOXX International Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
Via Benzinga
Week In Review: Mundipharma Considers $1 Billion Sale Of China Operations
Via Talk Markets
Week In Review: Novartis In $1 Billion Deal For DTx Pharma
Via Talk Markets
12 Health Care Stocks Moving In Monday's Intraday Session
Via Benzinga
Week In Review: Sino Biopharma Subsidiary Enters $307 Million Agreement For Rights To NASH Candidate
Via Talk Markets
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Why NanoVibronix Shares Surged Over 25%; Here Are 82 Biggest Movers From Friday
Via Benzinga
Week In Review: Beijing BoomRay Closes $43 Million A Round For Novel Radionuclide Drugs
Via Talk Markets
$2.2 Million Bet On Terns Pharmaceuticals? Check Out These 4 Penny Stocks Insiders Are Buying
Via Benzinga
CASI Pharmaceuticals Earnings Perspective: Return On Capital Employed
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.